Literature DB >> 10225881

Differential expression of Vibrio vulnificus capsular polysaccharide.

A C Wright1, J L Powell, M K Tanner, L A Ensor, A B Karpas, J G Morris, M B Sztein.   

Abstract

Vibrio vulnificus is a human pathogen whose virulence has been associated with the expression of capsular polysaccharide (CPS). Multiple CPS types have been described; however, virulence does not appear to correlate with a particular CPS composition. Reversible-phase variation for opaque and translucent colony morphologies is characterized by changes in CPS expression, as suggested by electron microscopy of cells stained nonspecifically with ruthenium red. Isolates with opaque colony morphologies are virulent and appear to be more thickly encapsulated than naturally occurring translucent-phase variants, which have reduced, patchy, or absent CPS. Previously, we have shown that the virulence of translucent-phase variants was intermediate between opaque-phase variants and acapsular transposon mutants, suggesting a correlation between virulence and the amount of CPS expressed. In the present study, CPS expression of phase variants and genetically defined mutants of V. vulnificus M06-24/O was examined by using a CPS-specific monoclonal antibody with an enzyme-linked immunosorbent assay, flow cytometry, and immunoelectron microscopy. Semiquantitative analyses of CPS expression correlated well among these assays, confirming that the translucent-phase variant was intermediate in CPS expression and retained type I CPS-specific epitopes. Cell surface expression of CPS varied with the growth phase, increasing during logarithmic growth and declining in stationary culture. Significantly greater CPS expression (P = 0.026) was observed for cells grown at 30 degrees C than for those at 37 degrees C. These studies confirm that phase variation and virulence in V. vulnificus correlate with the amount of CPS expressed and demonstrate the fluidity of bacterial polysaccharide expression in response to environmental conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225881      PMCID: PMC115964     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Monoclonal antibodies as probes for detecting lipopolysaccharide expression on Escherichia coli from different growth conditions.

Authors:  D Nelson; A J Bathgate; I R Poxton
Journal:  J Gen Microbiol       Date:  1991-12

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli.

Authors:  C Vermeulen; A Cross; W R Byrne; W Zollinger
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

4.  Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera.

Authors:  A S Kreger; L D Gray; J Testa
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

5.  Isolation and characterization of Vibrio vulnificus from two Florida estuaries.

Authors:  M Tamplin; G E Rodrick; N J Blake; T Cuba
Journal:  Appl Environ Microbiol       Date:  1982-12       Impact factor: 4.792

6.  Distribution of Vibrio vulnificus in the Chesapeake Bay.

Authors:  A C Wright; R T Hill; J A Johnson; M C Roghman; R R Colwell; J G Morris
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

7.  Classification of Vibrio vulnificus strains by the carbohydrate composition of their capsular polysaccharides.

Authors:  C A Bush; P Patel; S Gunawardena; J Powell; A Joseph; J A Johnson; J G Morris
Journal:  Anal Biochem       Date:  1997-08-01       Impact factor: 3.365

8.  Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide.

Authors:  L C Paoletti; R A Ross; K D Johnson
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells.

Authors:  D E Craven; M S Peppler; C E Frasch; L F Mocca; P P McGrath; G Washington
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

10.  An ancestral mutation enhancing the fitness and increasing the virulence of Haemophilus influenzae type b.

Authors:  J S Kroll; E R Moxon; B M Loynds
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

View more
  32 in total

1.  Role of flagellum and motility in pathogenesis of Vibrio vulnificus.

Authors:  Jong-Ho Lee; Jong Bok Rho; Kyung-Je Park; Chang Beom Kim; Yang-Soo Han; Sang Ho Choi; Kyu-Ho Lee; Soon-Jung Park
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

2.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  Evidence for an intermediate colony morphology of Vibrio vulnificus.

Authors:  Thomas M Rosche; Ben Smith; James D Oliver
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

4.  Genetic distinctions among clinical and environmental strains of Vibrio vulnificus.

Authors:  Maria Chatzidaki-Livanis; Michael A Hubbard; Katrina Gordon; Valerie J Harwood; Anita C Wright
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

Review 5.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

6.  Identification of the Vibrio vulnificus wbpP gene and evaluation of its role in virulence.

Authors:  Na Young Park; Jeong Hyun Lee; Myung Won Kim; Hee Gon Jeong; Byung Cheol Lee; Tae Sung Kim; Sang Ho Choi
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

7.  Identification and characterization of a novel outer membrane protein receptor required for hemin utilization in Vibrio vulnificus.

Authors:  Shreya Datta; Jorge H Crosa
Journal:  Biometals       Date:  2011-10-21       Impact factor: 2.949

8.  Roles of RseB, sigmaE, and DegP in virulence and phase variation of colony morphotype of Vibrio vulnificus.

Authors:  Roslyn N Brown; Paul A Gulig
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

9.  Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Authors:  A M Starks; T R Schoeb; M L Tamplin; S Parveen; T J Doyle; P E Bomeisl; G M Escudero; P A Gulig
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

10.  Expression of Vibrio vulnificus capsular polysaccharide inhibits biofilm formation.

Authors:  Lavin A Joseph; Anita C Wright
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.